364970.KS
Get informed when a big investor buys or sells
+ Follow| Market cap | $261.18 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $45.00 (0.68%) |
| Earnings per Share | $- |
| Beta | 0.31 |
| Outstanding Shares | - |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
The TIGER BIO NEWDEAL ETF is designed to deliver investment returns that broadly mirror the overall performance of the KRX Bio TOP 10 Index. Its objective is to reflect both the capital appreciation and income generated by the index, calculated prior to the deduction of any fund expenses.